Assessing the benefits of lipid-lowering therapy

This publication has 24 references indexed in Scilit:

• Cost-Effectiveness of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitor Therapy in the Managed Care Era
  The American Journal of Cardiology, 1996
• Task force 6. Cost effectiveness of assessment and management of risk factors
  Journal of the American College of Cardiology, 1996
• Treating Elevated Cholesterol Levels: The Great Satan in Perspective
  The Journal of Clinical Pharmacology, 1996
• Unresolved issues in early trials of cholesterol lowering
  The American Journal of Cardiology, 1995
• Should there be a moratorium on the use of cholesterol lowering drugs?
  BMJ, 1992
• Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
  BMJ, 1990
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986
• Xanthomata, Hypercholesterolemia, Angina Pectoris.
  Acta Medica Scandinavica, 1938